First-Line Treatment for Smoking Cessation
Varenicline (Chantix) 1mg twice daily is the most effective first-line pharmacotherapy for smoking cessation, with combination counseling and behavioral therapy being essential components of successful treatment. 1, 2
Pharmacotherapy Options
First-Line Medications (in order of effectiveness)
Varenicline (Chantix)
Combination Nicotine Replacement Therapy (NRT)
- Long-acting NRT (patch) plus short-acting NRT (gum, lozenge, inhaler, or nasal spray)
- Provides steady background nicotine levels with ability to address acute cravings 2
Bupropion SR
- Dosing: 150mg once daily for 3 days, then 150mg twice daily for 7-12 weeks
- May help with weight management concerns during cessation 2
- Can be used alone or in combination with NRT
Behavioral Therapy/Counseling
Behavioral therapy is essential and should be provided alongside pharmacotherapy:
- Minimum recommendation: 4 or more sessions during each 12-week course of pharmacotherapy 1
- Session duration: 10-30+ minutes per session (longer sessions linked to higher success rates) 1
- Even brief counseling (≤3 minutes) increases quit rates significantly 1
- Counseling content should include:
- Problem-solving skills
- Coping strategies for nicotine withdrawal
- Identifying smoking triggers
- Strategies for high-risk situations 1
Treatment Algorithm
Assessment:
- Assess tobacco use at every visit
- Evaluate level of nicotine dependence
- Review previous quit attempts and what worked/didn't work
Advise and Set Quit Date:
- Provide clear, strong advice to quit
- Set a specific quit date (within 2-4 weeks)
Select Pharmacotherapy:
- First choice: Varenicline 1mg twice daily for 12 weeks
- Alternative options if varenicline is contraindicated:
- Combination NRT (patch plus short-acting form)
- Bupropion SR 150mg twice daily
Implement Behavioral Support:
- Provide in-person counseling or refer to telephone quitline
- Schedule follow-up within 2 weeks of quit date
- Address specific barriers and high-risk situations
Follow-up and Relapse Prevention:
- Monitor for withdrawal symptoms and side effects
- Consider extending pharmacotherapy to 6 months for successful quitters
- Develop specific relapse prevention strategies
Special Populations
- Pregnant women: Counseling is first-line; if unsuccessful, consider short-acting NRT 1
- Hospitalized patients: Excellent opportunity to begin treatment with counseling and NRT 1
- Patients with COPD/cardiovascular disease: Varenicline has shown effectiveness in these populations 3, 4
Common Pitfalls to Avoid
- Inadequate treatment duration: Minimum 12 weeks of pharmacotherapy recommended
- Using monotherapy only: Combination approaches (medication + counseling) are more effective
- Failing to follow up: Schedule follow-up within 2 weeks of quit date
- Treating all quit attempts the same: Tailor approach based on previous attempts
- Viewing failure as permanent: Tobacco dependence is a chronic condition requiring repeated intervention 2
Remember that smoking cessation significantly reduces morbidity and mortality, and improves quality of life. Multiple quit attempts are often necessary before achieving long-term abstinence, so persistence and continued support are essential.